Find and Pitch Jounalists, Get Your Story Covered

Tags: Monoclonal Antibodies Cancer Antibody Research Bispecific Antibodies DLBCL Trials

	Profile	Recent Articles on Subject
1	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’ - 21 days ago Merck Picks Up Novel Bispecific Antibody With Potential in Both Cancer & Autoimmune Disease - 3 months ago Ipsen Turns to China-Based Biotech to Get Another ADC Cancer Drug - 4 months ago
2	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 22 days ago FDA Approves Axatilimab-csfr for cGVHD - 3 months ago Addressing Challenges When Implementing Bispecific Antibodies in Diverse Settings - 5 months ago Addressing the Challenges of Implementing Bispecific Antibodies in Health Care Centers - 7 months ago Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma - 7 months ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 2 months ago Novel Monoclonal Antibody Reduces Bleeds in Hemophilia A and B - 11 months ago Year in Review: Follicular Lymphoma - 12 months ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago
4	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 2 months ago Medicare Lags, Medicaid Leads for Biosimilar Uptake - 3 months ago
5	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	Oncimmune announces new contract with global pharma company - 3 months ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma - 5 months ago FDA Accepts sBLA for Bimekizumab-bkzx in Hidradenitis Suppurativa Treatment - 7 months ago FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications - 8 months ago FDA Approves 2 Denosumab Biosimilars for All Indications of Reference Products - 8 months ago FDA Grants Priority Review to Epcoritamab-bysp for Relapsed or Refractory Follicular Lymphoma - 9 months ago Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months - 9 months ago Biosimilar SB8 Is Comparable to Bevacizumab for Non–Small Cell Lung Cancer - 9 months ago FDA Approves Targeted Release Budesonide for Treatment of Primary Immunoglobulin A Nephropathy - 11 months ago
7	Elizabeth Short MedPage Today Editorial intern @medpagetoday. New York, New York Journalismediting	Novel Antibody for Chronic Hives Brings Relief in Mid-Stage Trial - 9 months ago
8	Ryan Haumschild Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia pharmacyhealthcareeditorial workadvisory	Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody - 9 months ago
9	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery - 9 months ago Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery - 9 months ago
10	Erin Hunter, Assistant Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	More than 80% of Patients with Diffuse Large B-cell Lymphoma Responded to Novel Therapeutic, according to the Results of a Preclinical Trial - 11 months ago Trial-In-Progress Looks to Prophylactic Tocilizumab to Reduce CRS in Patients with Multiple Myeloma - 11 months ago FDA Approves Interchangeable Biosimilar Ustekinumab-auub for Inflammatory Diseases - about 1 year ago

Journalists covering Bispecific Antibodies